Literature DB >> 12622551

The use of genetic markers in the clinical care of patients with head and neck cancer.

Paul L Friedlander1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12622551     DOI： 10.1001/archotol.129.3.363

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN： 0886-4470


× No keyword cloud information.
  3 in total

1.  Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer.

Authors:  B S M S Siriwardena; Y Kudo; I Ogawa; M Kitagawa; S Kitajima; H Hatano; W M Tilakaratne; M Miyauchi; T Takata
Journal:  Br J Cancer       Date:  2006-10-24       Impact factor: 7.640

2.  CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.

Authors:  Gitali Ganguli-Indra; Christine Wasylyk; Xiaobo Liang; Regine Millon; Mark Leid; Bohdan Wasylyk; Joseph Abecassis; Arup K Indra; Arup Indra
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

3.  Telomeric Repeat-Containing RNAs (TERRA) Decrease in Squamous Cell Carcinoma of the Head and Neck Is Associated with Worsened Clinical Outcome.

Authors:  Valerio Vitelli; Paolo Falvo; Solomon G Nergadze; Marco Santagostino; Lela Khoriauli; Paola Pellanda; Giulia Bertino; Antonio Occhini; Marco Benazzo; Patrizia Morbini; Marco Paulli; Camillo Porta; Elena Giulotto
Journal:  Int J Mol Sci       Date:  2018-01-17       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.